Intravenous immune globulin therapy of lupus nephritis: Use of pathogenic anti-DNA-reactive IgG

Clinical and Experimental Immunology, Supplement

Volumn 104, Issue SUPPL. 1, 1996, Pages 91-97

  Silvestris, F ^a   D'Amore, O ^a   Cafforio, P ^a   Savino, L ^a   Dammacco, F ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anti DNA; Idiotypes; IL 6; IVIG; Lupus nephritis; TNF

Indexed keywords

DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; CHROMATOGRAPHY, AFFINITY; DNA; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029965906     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326:107-11.
2. Kaveri SV, Dietrich G, Hurez V et al. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune disease. Clin Exp Immunol 1991; 86:192-8.
3. Jayne DRW, Davies MJ, Fox CJV et al. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337:1137-9.
4. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994; 94:1729-35.
5. Dammacco F, Iodice G, Campobasso N. Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effect on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol 1986; 62:125-31.
6. Dietrich G, Kaveri SV, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992; 62:573-81.
7. Rossi F, Kazatchkine MD. Anti-idiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989; 143:4104-12.
8. Evans MJ, Suenaga R, Abdou NI. Detection and purification of anti-idiotypic antibody against anti-DNA in intravenous immune globulin. J Clin Immunol 1991; 11:291-5.
9. + lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10:364-8.
10. Livneh A, Or G, Many A et al. Anti-DNA antibodies secreted by peripheral B cells of lupus patients have both normal and lupus-specific features. Clin Immunol Immunopathol 1993; 68:68-73.
11. Sultan Y, Rossi F, Kazatchkine MD. Recovery from anti-VIIIc (anti-hemophilic factor) autoimmune disease is dependent on generation of anti-idiotypes against anti-VIIIc autoantibodies. Proc Natl Acad Sci USA 1987; 84:828-31.
12. Dietrich G, Algiman M, Sultan Y et al. Origin of anti-idiotypic activity against autoantibody in pools of normal human immunoglobulin G (IVIG). Blood 1992; 79:1-5.
13. Rigal D, Vermont-Desroches C, Heitz S et al. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortion: specific effects on LFA-1 and CD56 molecules. Clin Immunol Immunopathol 1994; 71:309-10.
14. Aukrust P, Fröland SS, Liaback NB et al. Release of cytokines, soluble cytokines receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 1994; 84:2136-43.
15. Akashi K, Nagasawa K, Mayimi T et al. Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. J Rheumatol 1990; 17:375-9.
16. Jordan SC. Intravenous γ-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 1989; 53:8164-9.
17. Suzuki N, Harada T, Mizushima Y et al. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus. J Immunol 1993; 151:1128-36.
18. Suenaga R, Abdou NI. Cationic and high affinity serum IgG anti-Ids DNA antibodies in active lupus nephritis. Clin Exp Immunol 1993; 94:418-22.
19. Vernier RL, Klend J, Sisson SP et al. Heparan sulfate-rich anionic sites in the human glomerular basement membrane: decreased concentration in congenital nephrotic syndrome. N Engl J Med 19 309:1001-9.
20. Silvestris F, Cafforio P, Dammacco F. Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin Exp Immunol 1994; 97:19-25.
21. + anti-DNA antibodies in SLE. Arthritis Rheum 1992; 35:553-9.
22. Paul E, Iliev AA, Livneh A et al. The anti-DNA-associated idiotype 8.12 is encoded by the V lambda II gene family and maps to the vicinity of L chain CDR1. J Immunol 1992; 149:3588-95.
23. Andersson UG, Björk L, Skansén-Saphir U et al. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled IgG. Immunology 1993; 79:211-17.
24. Ling ZD, Yeoh E, Webb BT et al. Intravenous immunoglobulin induces interferon-γ and interleukin-6 in vivo. J Clin Immunol 1993; 13:303-8.
25. Pirani CL, Pollak VE. The kidney in systemic lupus erythematosus (SLE) glomerulonephritis (lupus nephritis). In: McCluskey RT, Andres GA, eds. Immunologically Mediated Renal Diseases. New York: Marcel Dekker, 1978:19-25.
26. 2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 59:256-70.
27. Williamson AR. Isoelectric focusing of immunoglobulins. In: Weir DM, ed. Handbook of Experimental Immunology. Oxford: Blackwell Scientific Publications, 1978; vol.I: 9.1-9.31.
28. 2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosus. Arthritis Rheum 1984; 27:1387-96.
29. Quinti I, Paganelli R, Scala E et al. Hepatitis C virus antibodies in gammaglobulin. Lancet 1990; 336:377.
30. Dodd LG, McBride JH, Gitnick GL et al. Prevalence of non-A, non-B hepatitis/hepatitis C virus antibody in human immunoglobulins. Am J Clin Pathol 1992; 97:108-13.
31. Madaio MP, Schattner A, Schattner M et al. Lupus serum and normal human serum contain anti-DNA antibodies with the idiotypic marker. J Immunol 1986; 137:2535-40.
32. Karounos DG, Grudier JP, Pisetsky DS. Spontaneous expression of antibodies to DNA of various species origin in sera of normals and patients with SLE. J Immunol 1988; 140:451-5.
33. Abdou NI, Suenaga R, Hatfield M et al. Regulation of anti-DNA antibodies by anti-idiotypic antibodies in sera of families of lupus patients. In: Reichlin M, Capra JD, eds. Idiotypes. New York: Academic Press, 1986:95-107.
34. Tomino Y, Sakai H, Takaya M et al. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gammaglobulin in patients with lupus nephritis. Clin Exp Immunol 1984; 58:42-8.
35. Akira S, Hirano T, Taga T et al. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990; 4:2860-4.
36. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991; 163:1177-83